Cargando…
Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma
BACKGROUND: Cytotoxic drugs are non-selective between normal and pathological tissue, and this poses a challenge regarding the strategy for treatment of tumors. To achieve sufficient antitumor activity for colorectal carcinoma, optimization of the therapeutic regimen is of great importance. We inves...
Autores principales: | Yang, Chuang, Liu, Hai Z, Fu, Zhong X, Lu, Wei D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064655/ https://www.ncbi.nlm.nih.gov/pubmed/21401960 http://dx.doi.org/10.1186/1472-6750-11-21 |
Ejemplares similares
-
Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review)
por: YANG, CHUANG, et al.
Publicado: (2014) -
Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes
por: Cheraga, Nihad, et al.
Publicado: (2021) -
Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
por: Li, Yanan, et al.
Publicado: (2020) -
Preparation and Evaluation of Intraperitoneal Long-Acting Oxaliplatin-Loaded Multi-Vesicular Liposomal Depot for Colorectal Cancer Treatment
por: Abuzar, Sharif Md, et al.
Publicado: (2020) -
XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
por: Huang, Ming-Yii, et al.
Publicado: (2023)